Device Trial Radar · NCT05742009
iCare ST500 Clinical Trial
Last checked: Nov 19, 2026Latest source record: Nov 30, 2023 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
165
Actual
Start
Jun 5, 2023
Primary completion
Nov 14, 2023
Study completion Nov 14, 2023
Sponsor
- Lead sponsor
- Icare Finland OyNot on our public-company list
- Sponsor type
- Industry
- First posted
- Feb 23, 2023
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Diagnostic
- FDA-regulated device
- No
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
Clinical validation of iCare ST500 tonometer per ANSI Z80.10:2014 standard
Conditions
- Intraocular Pressure
Interventions
iCare ST500Device
Measurement of Intraocular Pressure (IOP)
GATDevice
Measurement of Intraocular Pressure (IOP)
iCare IC200Device
Measurement of Intraocular Pressure (IOP)
Primary outcomes
What the sponsor says the trial is designed to measure.
- Demonstrate compliance with ANSI Z80.10:2014-Ophthalmics-Ophthalmic Instruments-TonometersTime frame: Through study completion, an average of 4 months
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Nova Scotia Health/Dalhousie University
Halifax, Nova Scotia, Canada
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.